Key takeaways:
- Wegovy, a weight loss injectable manufactured by Novo Nordisk, is now approved by the CDSCO in India.
- The injection’s active ingredient, Semaglutide, helps reduce appetite and achieve weight loss.
- Wegovy will be sold in India in 5 doses: 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg.
- Overweight or obese Indians with a BMI of more than 27 are eligible to take Wegovy.
- At Aktive, Wegovy’s price starts at ₹19,345 per month.
But, the average obese person in India had yet to experience how a shot can dissolve his/her weight loss struggle.
🎉 The wait ended on June 25, 2025, when Danish manufacturer Novo Nordisk officially launched weight loss injection Wegovy in India.
Which means, overweight or obese Indians can now lose weight from the comfort of their homes with this weight loss injection.
If you are struggling with weight loss, Wegovy might be the solution for you. No hard diets. No intensive gym sessions - you can drop your weight with just one injection every week.
In this article, let us dive deep into:
- What is Wegovy?
- How does it work?
- Does it have any side effects?
- What is Wegovy priced in India?
Read on to find out.
Wegovy launched in India
After pharmaceutical giant Eli Lilly’s Mounjaro launch in India back in March 2025, global pharmaceutical company Novo Nordisk decided to step up its game by capturing the Indian anti-obesity drug market with Wegovy’s launch.
Wegovy will be sold in India as a once-weekly FlexTouch pre-filled injection pen along with four disposable needles, making it easy to use.
Vikram Shrotriya, Managing Director, Novo Nordisk India, shared, “Obesity is not just a personal health concern - it is a chronic disease and a national epidemic that India cannot afford to ignore. We are bringing Wegovy with the convenience of a world-class, state-of-the-art pen device, and an India-specific price.”
Is Wegovy already available in India?
Wegovy has already launched in India and is available on Aktive.
What does Wegovy cost in India?
At Aktive, the cost of Wegovy will vary depending on the dosage.
Price starts from ₹19,345 per month
Why choose Aktive:
- Quick 5-minute health assessment
- Treatment approved by licensed partner doctors
- Personalised diet & fitness plan
- Free doorstep delivery
How does Wegovy work?
Wegovy is made of semaglutide, which is a GLP-1 receptor agonist. Semaglutide mimics the GLP-1 hormone in the body and does the following:

Releases insulin
The GLP-1 hormone signals the pancreas to release insulin when blood sugar levels rise. This moves sugar into the cells to generate energy.

Slows digestion
The hormone slows down the pace of food movement through the stomach. This results in feeling fuller for longer after eating.

Reduces sugar production in the liver
The hormone decreases sugar production in the liver when it is not required.

Controls appetite
GLP-1 also affects the areas of the brain that control appetite. As a result, you end up feeling less hungry.
All these actions eventually lead to gradual weight loss.
How much weight can you lose on Wegovy?
Wegovy does help users lose significant weight.
A 68-week study was conducted with 1961 participants. These participants were either obese or overweight with at least one obesity-related medical condition.
Some participants were administered a Wegovy injection along with a reduced-calorie diet and exercise, while others were given a placebo along with diet and exercise.
The average starting weight of both groups was 105 kg.
The results at the end of the study were as follows:
However, these figures are not set in stone. Depending on various individual factors, such as your starting weight, medical history, and lifestyle habits, your weight loss journey with Wegovy can look different from other people.
Patience, diet, and exercise can go a long way in supporting your weight loss efforts with Wegovy.
Are you eligible to take Wegovy?
Although Wegovy helps people effortlessly lose weight, can any obese or overweight person take the weight loss injection in India?
Wegovy is a prescription-only weight loss injection.
This means you need a doctor’s prescription to take it for weight loss. This also means that your doctor should find it reasonable to prescribe Wegovy to you.
You are eligible for Wegovy if you have:
A BMI of:
> 30 kg/m2
> 27 kg/m2 with at least one weight-related medical condition, such as:
- Prediabetes
- Type 2 diabetes
- High blood pressure
- History of heart attack or stroke
- You have type 2 diabetes, and all other forms of medication have failed to manage it
You might not be eligible to take Wegovy if you have:
- Type 1 diabetes
- Pancreatitis (inflammation in the pancreas)
- Personal or family history of Medullary Thyroid Carcinoma (MTC), a type of thyroid cancer
- Multiple Endocrine Neoplasia Syndrome Type 2 (MEN 2)
- Allergy to Wegovy or any of the ingredients present in Wegovy
Inform your doctor if any or all of the following apply to you before taking Wegovy:
- You are taking birth control pills
- You have severe problems with your stomach or kidneys, such as gastroparesis (slowed emptying of the stomach)
- You are taking other diabetic medicines, such as sulfonylureas or insulin
- You have a history of diabetic retinopathy (vision issues due to diabetes)
- You are scheduled for surgery that involves anaesthesia or sleep medicines
- You are pregnant or planning to become pregnant
- You are breastfeeding or planning to breastfeed
Wegovy dosages in India
In India, Wegovy will be available in the following dosages: 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg.
This is what a usual Wegovy dosage chart looks like:
How to take Wegovy
Taking the Wegovy injection for weight loss is quite an easy process.
Wegovy is available as FlexTouch, a pre-filled injection pen.
What’s inside a Wegovy package?
Inside a Wegovy package, you get:
- 1 pre-filled injection pen
- 4 disposable needles
Wegovy is designed to be taken once a week. It is to be taken under the skin (subcutaneously).
Ideal injection sites for Wegovy:
- Stomach (2 inches away from the belly button)
- Upper thighs
- Upper arms
Pro tip:
You can inject Wegovy in the same body part each week, but ensure that you rotate the areas on that particular body part to avoid irritation.
It is advised that you take Wegovy on the same day, at the same time every week.
Wegovy can be self-injected. For first-time users, a healthcare professional can demonstrate how to inject Wegovy.
Does Wegovy have any side effects?
Every medicine comes with a few side effects. Wegovy is no exception.
Some of the most common Wegovy side effects (occur in more than 1 of 10 people) include:
- Headache
- Nausea
- Vomiting
- Diarrhoea
- Constipation
- Stomach pain
- Fatigue
Common side effects (affecting 1 in 10 people) include:
- Feeling dizzy
- Upset stomach
- Burping
- Gas
- Bloating in the stomach
- Gastritis (inflamed stomach)
- Acid reflux or heartburn
- Hair loss
- Injection site reactions
- Change in taste
- Low blood sugar (hypoglycemia) in diabetic patients
Wegovy also has some serious but rare side effects. These include:
- Pancreatitis (inflammation of the pancreas)
- Gallbladder problems
- Hypoglycemia (low blood sugar)
- Kidney failure
- Vision change in type 2 diabetics
- Increased heart rate
- Depression/suicidal thoughts
- Allergic reactions (swelling of face, nose, lips)
- Rash
- Difficulty swallowing/breathing
These side effects usually subside within a few days to a few weeks.
What are the alternatives to Wegovy?
The anti-obesity market in India is on a steep rise. Owing to this, many major international pharmaceutical companies are in the race to dominate the region.
Wegovy isn’t the only weight loss injection available to overweight or obese Indians. Prior to its launch, Eli Lilly entered the market in March 2025 with the weight loss drug Mounjaro.
Here is a clear comparison between Mounjaro and Wegovy so you can choose what’s best for your weight loss goals.
Category | Mounjaro | Wegovy |
---|---|---|
Average weight loss | Upto 21% body weight in 16 months[1] | Upto 15% body weight in 16 months[2] |
When to take | Once every week | Once every week |
Available as | Injection pen (KwikPen) or vial | Injection pen (FlexTouch) |
Common side effects | Feeling sick (nausea), vomiting, diarrhoea, stomach pain | Feeling sick (nausea), vomiting, diarrhoea, fatigue |
Added benefits | Also helps manage type 2 diabetes in people with diabetes | May help protect the heart in people with existing heart conditions |
Price | Starts at ₹16,000 per month | Starts at ₹19,345 per month |
Active ingredient | Tirzepatide | Semaglutide |
How it works | Mimic GLP-1 and GIP hormones to reduce appetite, control blood sugar, and support weight loss. | Mimics GLP-1 hormone to reduce appetite and support weight loss. |
If you are on the fence when it comes to Mounjaro vs Wegovy, check this out:
Looking for an oral alternative to weight loss injections?
Rybelsus, manufactured by Novo Nordisk, is approved in India for type 2 diabetes management, but since it shares the same active ingredient as Wegovy, Rybelsus is also prescribed off-label for weight loss.
Wegovy for weight loss: Now available at Aktive
If you are looking for a safe, effective, and sustainable weight loss with Wegovy, your search ends at Aktive’s weight loss programme.
Get your Wegovy injection for weight loss at Aktive, and lose upto 15% of your body weight in 16 months. No restrictive diets. No intense workout schedules.
Just pure weight loss, right from the comfort of your home.
Check if you are eligible for WegovyFAQs
-
What should I do if my Wegovy injection pen isn’t working correctly?
-
Why are there different coloured Wegovy injection pens?
-
Can I change the day or time to take the Wegovy injection?
-
Do I have to take Wegovy on an empty stomach?
-
Can I travel with Wegovy?
-
I am nervous at the thought of injecting myself with Wegovy. What should I do?
-
Is there a generic version of Wegovy?
-
If a generic version is available in the grey market, is it okay to use it instead of the actual Wegovy injection?
-
Is Ozempic a substitute for Wegovy?
References:
- [1] Aronne, L. J., Sattar, N., Horn, D. B., Bays, H. E., Wharton, S., Lin, W., Ahmad, N. N., Zhang, S., Liao, R., Bunck, M. C., Jouravskaya, I., Murphy, M. A., Fretes, J. O., Coronel, M. J., Gutnisky, L. L., Frechtel, G. D., Gelersztein, E., Aizenberg, D., Maldonado, N., . . . Nardandrea, J. P. (2023). Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity. JAMA, 331(1), 38. https://doi.org/10.1001/jama.2023.24945
- [2] Garvey, W. T., Batterham, R. L., Bhatta, M., Buscemi, S., Christensen, L. N., Frias, J. P., Jódar, E., Kandler, K., Rigas, G., Wadden, T. A., & Wharton, S. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083–2091. https://doi.org/10.1038/s41591-022-02026-4